Health insurance; require health benefit plans to follow new procedure related to step therapy protocol for CRF-COPD treatment.
SB 2069 creates a new Mississippi insurance code section requiring health benefit plans that use step therapy for chronic respiratory failure consequent to chronic obstructive pulmonary disease (CRF-COPD) to provide a clear, transparent exception process. The bill allows a participant, beneficiary, prescribing provider, or designated advocate to request an override when the preferred treatment is not as effective, would be delayed to the patient’s detriment, is contraindicated, is likely to cause harm, would interfere with safe functioning, or when the disease is life-threatening. Plans must cover the requested treatment if the exception criteria are met, subject to the plan’s existing cost-sharing terms.
The bill also requires health plans to publish the exception process, forms, supporting information, and contact details on their websites. It limits the information a plan may demand to what is strictly necessary to decide the request and sets response deadlines: generally within 72 hours, or within one business day when delay could seriously jeopardize life or health. The act applies to licensed Mississippi providers and plans that use step therapy for respiratory care treatments, even if the policy is not labeled as such.
In addition to the new CRF-COPD-specific section, SB 2069 amends the existing step therapy statute, Section 83-9-36, to conform with the new provisions and clarifies that the new section does not fall under the older medication-focused override rules. The bill takes effect July 1, 2025, and would therefore become part of Mississippi’s insurance and utilization-management framework for covered respiratory therapies.
Because there are no committee transcripts or recorded votes in the provided materials, the overall sentiment cannot be measured from debate or floor action. Based on the bill text alone, the measure appears consumer- and patient-protective, aiming to speed access to medically necessary treatment and reduce administrative barriers for patients with serious respiratory disease. The absence of recorded opposition or amendments in the provided context suggests no documented controversy in the available record, though the bill’s requirements could be viewed as imposing additional compliance obligations on insurers and health benefit plans.
SB 2069 would add a new statutory exception process for step therapy protocols used in coverage of CRF-COPD respiratory treatments and would amend Mississippi Code Section 83-9-36 to align with the new framework. It affects health benefit plans, health insurance issuers, insurers, prescribing providers, and beneficiaries by requiring faster review timelines, website disclosures, and coverage of requested treatment when exception criteria are met. The bill would expand patient access protections within Mississippi insurance law and impose procedural duties on plans that use fail-first or step therapy utilization management.
No committee discussion or vote history was provided, so there is no recorded legislative debate to gauge sentiment from the available materials. The bill’s text reflects a generally supportive, patient-access-oriented approach, emphasizing transparency, expedited review, and medical necessity exceptions for serious respiratory conditions. In the absence of recorded opposition, the available context suggests the measure was framed as a health coverage protection rather than a controversial policy change.
The main policy tension in SB 2069 is between patient access to medically necessary respiratory treatment and insurer use of step therapy to manage costs and utilization. Supporters would likely favor the bill’s expedited exception process, limited documentation requirements, and short response deadlines for serious cases, while insurers may view those provisions as reducing their ability to enforce preferred-treatment protocols. The bill also narrows what plans may request from patients and providers, which could be seen as limiting administrative discretion. No specific objections, amendments, or named opponents appear in the provided record.